How muscles sense stretch

Molecular mediators of muscle spindle mechanosensation

NIH-funded research San Jose State University · NIH-11291304

This research looks at key proteins that let muscle sensors detect stretch to better understand movement and balance problems in conditions like aging, chemotherapy-related nerve damage, and certain genetic movement disorders.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionSan Jose State University NIH-funded
Lab location1 site (San Jose, United States)
Project IDNIH-11291304 on NIH RePORTER

What this research studies

From my perspective as someone affected by movement or balance problems, the team is using mouse models to study proteins that let muscle sensors (muscle spindle afferents) turn stretch into nerve signals. They focus on the PIEZO2 mechanosensor and other molecules like NaV1.1 and glutamate, and compare what happens when these proteins are altered during development versus only after the muscle spindle forms. The work measures how well the sensory nerves respond to stretch and how that changes movement-related signals. Results will help explain why proprioception fails in some conditions and point toward molecular targets for future therapies.

Who could benefit from this research

Good fit: People with balance or movement problems due to aging, chemotherapy-related peripheral neuropathy, or inherited disorders that impair proprioception (for example distal arthrogryposis) are the kinds of patients who might benefit from follow-up studies or future therapies.

Not a fit: Patients seeking an immediate treatment or those with conditions unrelated to muscle proprioception are unlikely to receive direct benefit from this lab-based mouse research.

Why it matters

Potential benefit: If successful, this work could point to new molecular targets to improve proprioception, balance, and motor control in people with aging-related decline, chemotherapy-induced neuropathy, or inherited proprioceptive disorders.

How similar studies have performed: Previous work has shown PIEZO2 is essential for normal stretch sensitivity and that mutations affect proprioception, but using timing of protein dysfunction during development versus after development to explain outcomes is a newer question.

Where this research is happening

San Jose, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Angelman Syndrome
Last reviewed 2026-06-09 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.